Sonuç Sayfası 2 için Endüstri: İlaç Üreticileri-Genel Borsası - Teklifler ve Fiyatlar
Fiyatlar, Piyasa Değerleri, PE ve EPS oranları ile tüm Hisse ve Net Varlıkların Listesi
Tüm ülkeler
- {{country.name}}
- Tüm ülkeler
- Amerika Birleşik Devletleri (49)
- Arjantin (13)
- Avustralya (1)
- Avusturya (13)
- Brezilya (14)
- Kanada (2)
- Şili (4)
- Çin (12)
- Finlandiya (2)
- Fransa (3)
- Almanya (58)
- Hong Kong (2)
- Macaristan (1)
- Hindistan (20)
- İtalya (5)
- Japonya (9)
- Meksika (14)
- Singapur (1)
- Güney Kore (3)
- ispanya (1)
- İsveç (3)
- İsviçre (6)
- Tayvan (1)
- Türkiye (1)
- Birleşik Krallık (20)
Tüm borsalar
- {{item.name}}
- Tüm borsalar
- ASX (1)
- BSE (10)
- Budapest (1)
- Buenos Aires (13)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (45)
- Helsinki (2)
- HKSE (2)
- IOB (17)
- Istanbul (1)
- KSE (3)
- LSE (3)
- MCE (1)
- Mexico (14)
- Milan (5)
- Munich (1)
- NasdaqCM (1)
- NasdaqGM (1)
- NasdaqGS (6)
- NSE (10)
- NYSE (8)
- OTC Markets OTCPK (28)
- OTC Markets OTCQX (5)
- Paris (3)
- Santiago (4)
- São Paulo (14)
- SES (1)
- Shanghai (6)
- Shenzhen (6)
- Stockholm (3)
- Swiss (6)
- Taipei Exchange (1)
- Tokyo (9)
- Vienna (13)
- XETRA (12)
Tüm sektörler
- {{item.name}}
- Tüm sektörler
- Sağlık Hizmetleri (265)
İlaç Üreticileri-Genel (265)
- {{item.name}}
- Tüm Sektörler
- Tarımsal Girdiler (323)
- Yapı Malzemeleri (471)
- Kimyasallar (596)
- Özel Kimyasallar (1365)
- Kereste ve Odun Üretimi (160)
- Kağıt ve Kağıt Ürünleri (269)
- Alüminyum (142)
- Bakır (217)
- Diğer Endüstriyel Metaller ve Madencilik (2762)
- Altın (1700)
- Gümüş (83)
- Diğer Değerli Metaller ve Madencilik (664)
- Kok Kömürü (72)
- Çelik (743)
- Otomobil ve Kamyon Bayileri (212)
- Otomobil Üreticileri (390)
- Otomobil Parçaları (1160)
- Rekreasyonel Taşıtlar (84)
- Döşemeler, Fikstürler ve Ev Eşyaları (509)
- Konut İnşaatı (214)
- Tekstil Üretimi (521)
- Giysi Üretimi (443)
- Ayakkabı ve Aksesuar (206)
- Ambalajlama ve Konteynerler (482)
- Kişisel Hizmetler (140)
- Restoranlar (538)
- Perakende Giyim (289)
- Büyük Mağazalar (276)
- Perakende Ev İyileştirme (106)
- Lüks Mallar (260)
- İnternet Üzerinden Perakende (407)
- Özel Perakende (547)
- Şans Oyunları (205)
- Dinlence (410)
- Konaklama (323)
- Tatil Yerleri ve Casino'lar (188)
- Seyahat Hizmetleri (193)
- Varlık Yönetimi (1966)
- Bankalar-Çeşitli (289)
- Bankalar-Bölgesel (2200)
- İpotek Finansı (171)
- Sermaye Piyasaları (887)
- Finansal Veriler ve Borsalar (152)
- Sigorta-Hayat (247)
- Sigorta-Mülk ve Hasar (266)
- Sigorta-Reasürans (72)
- Sigorta-Özel (72)
- Sigorta Komisyoncuları (67)
- Sigorta-Çeşitli (305)
- Paravan Şirketler (1821)
- Finansal Holdingler (102)
- Kredi Hizmetleri (663)
- Gayrimenkul-Geliştirme (876)
- Gayrimenkul Hizmetleri (1138)
- Gayrimenkul-Çeşitli (304)
- REIT-Sağlık Hizmetleri Tesisleri (63)
- REIT-Otel ve Motel (84)
- REIT-Endüstriyel (140)
- REIT-Ofis (168)
- REIT-Konut (106)
- REIT-Perakende (229)
- REIT-İpotek (129)
- REIT-Özel (83)
- REIT-Çeşitli (328)
- İçecekler-Bira Üreticileri (154)
- İçecekler-Şarap ve İçki İmalathaneleri (234)
- İçecekler-Alkolsüz (213)
- Şekerlemeciler (170)
- Çiftlik Ürünleri (608)
- Ev Eşyaları ve Kişisel Ürünler (523)
- Ambalajlı Gıdalar (1269)
- Eğitim ve Öğretim Hizmetleri (306)
- İndirim Mağazaları (96)
- Yemek Dağıtım (209)
- Marketler (233)
- Tütün (105)
- Biyoteknoloji (2608)
- İlaç Üreticileri-Genel (265)
- İlaç Üreticileri-Özel ve Genel (1632)
- Sağlık Hizmeti Planları (57)
- Tıbbi Bakım Tesisleri (554)
- Farmasötik Perakendeciler (155)
- Sağlık Bilgileri Hizmetleri (419)
- Tıbbi Cihazlar (916)
- Tıbbi Ekipmanlar ve Malzemeler (501)
- Teşhis ve Araştırma (429)
- Medikal Ürün Dağıtımı (138)
- Kamu Hizmetleri-Bağımsız Güç Üreticileri (150)
- Kamu Hizmetleri-Yenilenebilir (531)
- Kamu Hizmetleri-Su Tedariki (166)
- Kamu Hizmetleri-Elektrik Tedariki (437)
- Kamu Hizmetleri-Doğalgaz Tedariki (197)
- Kamu Hizmetleri-Çeşitli (202)
- Telekomünikasyon Hizmetleri (912)
- Reklam Ajansları (514)
- Yayımcılık (259)
- Yayıncılık (214)
- Eğlence (683)
- İnternet İçerikleri ve Bilgiler (527)
- Elektronik Oyunlar ve Multimedya (485)
- Petrol ve Gaz Sondajlama (80)
- Petrol ve Gaz Arama ve Üretimi (1187)
- Petrol ve Gaz - Entegre (246)
- Petrol ve Gaz - Orta Akım (232)
- Petrol ve Gaz Rafinesi ve Pazarlaması (277)
- Petrol ve Gaz Ekipmanları ve Hizmetleri (480)
- Termal Kömür (228)
- Uranyum (140)
- Hava-uzay ve Savunma (566)
- Özel İş Hizmetleri (638)
- Danışmanlık Hizmetleri (195)
- Kiralama ve Leasing Hizmetleri (222)
- Güvenlik ve Koruma Hizmetleri (266)
- İstihdam ve İşe Alım Hizmetleri (252)
- Holdingler (730)
- Mühendislik ve İnşaat (1494)
- Altyapı Operasyonları (156)
- Yapı Ürünleri ve Ekipmanları (510)
- Tarım ve Ağır İş Makineleri (377)
- Endüstriyel Dağıtım (234)
- İş Ekipmanları ve Malzemeleri (141)
- Özel Endüstriyel Makineler (1714)
- Metal Üretimi (393)
- Kirlilik ve Arıtma Kontrolleri (265)
- Araçlar ve Aksesuarlar (240)
- Elektrikli Ekipmanlar ve Parçalar (895)
- Havalimanları ve Hava Hizmetleri (134)
- Hava Yolları (230)
- Demir Yolları (261)
- Deniz Taşımacılığı (503)
- Kamyon Taşımacılığı (99)
- Entegre Nakliye ve Lojistik (389)
- Atık Yönetimi (355)
- Bilişim Teknolojileri Hizmetleri (1181)
- Yazılım-Uygulama (2025)
- Uygulama-Altyapı (928)
- İletişim Ekipmanları (732)
- Bilgisayar Donanımı (431)
- Tüketici Elektroniği (279)
- Elektronik Bileşenler (973)
- Elektronik Ürün ve Bilgisayar Dağıtımı (242)
- Bilimsel ve Teknik Gereçler (347)
- Yarı İletken Ekipman ve Malzemeler (349)
- Yarı İletkenler (608)
- Güneş Enerjisi (224)
| Ad Ad | Fiyat Fiyat |
24 sa.% 7g Grafikleri 24 sa.% 7g |
P. Değeri Piyasa değeri | HCM Hacim | 24s düşük | 24s yüksek | Piyasa değeri | F/K Oranı | HBK |
|---|
| Ad Ad | Fiyat Fiyat |
24 sa.% 7g Grafikleri 24 sa.% 7g |
P. Değeri Piyasa değeri | HCM Hacim | 24s düşük | 24s yüksek | Piyasa değeri | F/K Oranı | HBK | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Johnson & Johnson JNJ.SN | $156.65 — |
0
|
$376.91B — | $0 — | $145.55 — | $145.55 — | $376.91B — | 17.42 | $8.99 — | |
| AbbVie Inc. ABBV34.SA | $65.06 13.19 USD |
+0.68
|
$1.85T 374.41B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.85T 374.41B USD | 82.35 | $0.79 0.16 USD | |
| AbbVie Inc. ABBV.MX | $3,520.54 208.46 USD |
-2.21
|
$6.22T 368.22B USD | $3.22K 190.66 USD | $3,520.54 208.46 USD | $3,520.54 208.46 USD | $6.22T 368.22B USD | 78.86 | $44.64 2.64 USD | |
| Novartis AG NVS.BA | $38,500 45.51 USD |
-1.09
|
$305.47T 361.08B USD | $67 0.08 USD | $38,450 45.45 USD | $38,850 45.92 USD | $305.47T 361.08B USD | 2.39 | $16.1K 19.04 USD | |
| Johnson & Johnson JNJ.DE | $133.34 145.76 USD |
+0.39
|
$320.83B 350.71B USD | $592 647.14 USD | $133.02 145.41 USD | $133.38 145.8 USD | $320.83B 350.71B USD | 17.31 | $7.7 8.42 USD | |
| Johnson & Johnson JNJ.VI | $133.3 145.71 USD |
+0.38
|
$320.73B 350.6B USD | $11 12.02 USD | $133.22 145.63 USD | $133.3 145.71 USD | $320.73B 350.6B USD | 17.33 | $7.69 8.41 USD | |
| Johnson & Johnson JNJ.F | $132.8 145.17 USD |
+0.09
|
$319.53B 349.29B USD | $470 513.77 USD | $132.4 144.73 USD | $133 145.39 USD | $319.53B 349.29B USD | 17.22 | $7.71 8.43 USD | |
| AstraZeneca PLC AZN.BA | $44,250 52.3 USD |
-0.23
|
$275.57T 325.74B USD | $494 0.58 USD | $43,675 51.63 USD | $44,775 52.93 USD | $275.57T 325.74B USD | 7.05 | $6.27K 7.42 USD | |
| AbbVie Inc. ABBV.VI | $162.4 177.53 USD |
+0.37
|
$286.86B 313.58B USD | $0 0 USD | $162.2 177.31 USD | $162.4 177.53 USD | $286.86B 313.58B USD | 80.79 | $2.01 2.2 USD | |
| AbbVie Inc. 4AB.F | $162 177.09 USD |
+0.37
|
$286.16B 312.81B USD | $56 61.22 USD | $162 177.09 USD | $162 177.09 USD | $286.16B 312.81B USD | 80.59 | $2.01 2.2 USD | |
| AbbVie Inc. 4AB.DE | $161.8 176.87 USD |
+0.12
|
$285.8B 312.42B USD | $39 42.63 USD | $161.8 176.87 USD | $163 178.18 USD | $285.8B 312.42B USD | 79.31 | $2.04 2.23 USD | |
| Merck & Co., Inc. MRK.BA | $20,550 24.29 USD |
-0.6
|
$257.87T 304.81B USD | $3.61K 4.27 USD | $20,325 24.02 USD | $20,925 24.73 USD | $257.87T 304.81B USD | 0.23 | $86.83K 102.64 USD | |
| Roche Holding AG ROGN.MX | $6,067 359.24 USD |
0
|
$4.88T 288.8B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.88T 288.8B USD | 25.12 | $241.47 14.3 USD | |
| Merck & Co., Inc. MRK.PA | $101.4 110.84 USD |
0
|
$260.61B 284.88B USD | $250 273.28 USD | $100.2 109.53 USD | $101.6 111.06 USD | $260.61B 284.88B USD | 21.03 | $4.82 5.27 USD | |
| Novartis AG N1VS34.SA | $67.12 13.6 USD |
+0.1
|
$1.33T 269.64B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.33T 269.64B USD | 19.34 | $3.47 0.7 USD | |
| Novartis AG NVSN.MX | $2,092.19 123.88 USD |
0
|
$4.51T 267.29B USD | $0 0 USD | $2,092.19 123.88 USD | $2,092.19 123.88 USD | $4.51T 267.29B USD | 17.60 | $118.84 7.04 USD | |
| Roche Holding AG RHHBF | $346.65 — |
+4.1
|
$261.96B — | $1 — | $340 — | $340 — | $261.96B — | 26.80 | $12.93 — | |
| AstraZeneca PLC A1ZN34.SA | $64.5 13.07 USD |
+1.61
|
$1.22T 246.9B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.22T 246.9B USD | 29.05 | $2.22 0.45 USD | |
| Roche Holding AG RHO6.F | $34.6 37.82 USD |
+1.99
|
$222.13B 242.82B USD | $92 100.57 USD | $34.46 37.66 USD | $34.6 37.82 USD | $222.13B 242.82B USD | 24.71 | $1.4 1.53 USD | |
| AstraZeneca PLC AZNN.MX | $1,289.81 76.37 USD |
0
|
$4.07T 241.12B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.07T 241.12B USD | 27.85 | $46.3 2.74 USD | |
| Amgen Inc. AMGN.BA | $12,525 14.8 USD |
+0.2
|
$201.55T 238.24B USD | $1.46K 1.72 USD | $12,375 14.63 USD | $12,700 15.01 USD | $201.55T 238.24B USD | 0.18 | $69.22K 81.83 USD | |
| Merck & Co., Inc. MRCK34.SA | $57.91 11.74 USD |
+4.46
|
$1.17T 237.52B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.17T 237.52B USD | 12.89 | $4.49 0.91 USD | |
| Pfizer Inc. PFE.ST | $422.6 41.25 USD |
0
|
$2.42T 235.74B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.42T 235.74B USD | 0 | $0 0 USD | |
| Merck & Co., Inc. MRK.MX | $1,565 92.67 USD |
+3.44
|
$3.94T 233.39B USD | $1.01K 59.98 USD | $1,524.61 90.28 USD | $1,565 92.67 USD | $3.94T 233.39B USD | 12.63 | $123.91 7.34 USD | |
| Novartis AG NOTA.F | $103 112.59 USD |
+0.98
|
$206B 225.19B USD | $60 65.59 USD | $103 112.59 USD | $103 112.59 USD | $206B 225.19B USD | 18.72 | $5.5 6.01 USD | |
| AstraZeneca PLC AZNCF | $141.4 — |
+0.89
|
$219.2B — | $450 — | $140.15 — | $140.15 — | $219.2B — | 28.50 | $4.96 — | |
| Pfizer Inc. PFE.BA | $8,100 9.57 USD |
+0.75
|
$183.83T 217.3B USD | $40.8K 48.23 USD | $7,980 9.43 USD | $8,250 9.75 USD | $183.83T 217.3B USD | 2.32 | $3.48K 4.12 USD | |
| Merck & Co., Inc. MRK.SN | $83.87 — |
+6.04
|
$216.67B — | $0 — | $0 — | $0 — | $216.67B — | 12.19 | $6.88 — | |
| Gilead Sciences, Inc. GILD.BA | $34,950 41.31 USD |
-1.76
|
$176.7T 208.87B USD | $139 0.16 USD | $34,925 41.28 USD | $35,925 42.46 USD | $176.7T 208.87B USD | 5.81 | $6.01K 7.1 USD | |
| AstraZeneca PLC ZEGA.F | $61 66.68 USD |
+3.39
|
$190.72B 208.49B USD | $300 327.94 USD | $61 66.68 USD | $61 66.68 USD | $190.72B 208.49B USD | 28.50 | $2.14 2.34 USD | |
| AstraZeneca PLC ZEG.F | $120.05 131.23 USD |
+0.33
|
$188.79B 206.37B USD | $175 191.3 USD | $120.05 131.23 USD | $120.05 131.23 USD | $188.79B 206.37B USD | 28.65 | $4.19 4.58 USD | |
| Merck & Co., Inc. 6MK.DE | $71.5 78.16 USD |
+0.42
|
$179.54B 196.26B USD | $613 670.09 USD | $71.2 77.83 USD | $71.5 78.16 USD | $179.54B 196.26B USD | 12.39 | $5.77 6.31 USD | |
| Merck & Co., Inc. MRK.VI | $71.5 78.16 USD |
+0.42
|
$179.54B 196.26B USD | $0 0 USD | $71.4 78.05 USD | $71.5 78.16 USD | $179.54B 196.26B USD | 12.43 | $5.75 6.29 USD | |
| Merck & Co., Inc. 6MK.F | $71.3 77.94 USD |
-0.28
|
$179.04B 195.71B USD | $1.69K 1.84K USD | $71.3 77.94 USD | $71.6 78.27 USD | $179.04B 195.71B USD | 12.55 | $5.68 6.21 USD | |
| Amgen Inc. AMGN34.SA | $57.54 11.66 USD |
-0.57
|
$871.86B 176.71B USD | $0 0 USD | $0 0 USD | $0 0 USD | $871.86B 176.71B USD | 26.76 | $2.15 0.44 USD | |
| Amgen Inc. AMGN.MX | $5,550 328.63 USD |
0
|
$2.98T 176.71B USD | $21 1.24 USD | $0 0 USD | $0 0 USD | $2.98T 176.71B USD | 27.17 | $204.24 12.09 USD | |
| Pfizer Inc. PFIZ34.SA | $34.92 7.08 USD |
+0.4
|
$802.99B 162.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $802.99B 162.75B USD | 18.67 | $1.87 0.38 USD | |
| Pfizer Inc. PFE.MX | $474.17 28.08 USD |
-0.38
|
$2.71T 160.23B USD | $4.75K 281.26 USD | $471.02 27.89 USD | $477.88 28.3 USD | $2.71T 160.23B USD | 18.37 | $25.8 1.53 USD | |
| Amgen Inc. 0R0T.IL | $287.63 — |
+0.57
|
$157.63B — | $1 — | $0 — | $0 — | $157.63B — | 19.38 | $14.84 — | |
| Gilead Sciences, Inc. GILD34.SA | $305.77 61.97 USD |
+0.51
|
$771.46B 156.36B USD | $0 0 USD | $0 0 USD | $0 0 USD | $771.46B 156.36B USD | 23.70 | $12.9 2.61 USD | |
| Gilead Sciences, Inc. GILD.MX | $2,100 124.35 USD |
-0.64
|
$2.61T 154.68B USD | $1.54K 90.89 USD | $2,100 124.35 USD | $2,100 124.35 USD | $2.61T 154.68B USD | 23.54 | $89.19 5.28 USD | |
| Amgen Inc. AMG.DE | $252.2 275.69 USD |
-0.41
|
$135.61B 148.24B USD | $244 266.72 USD | $250.9 274.27 USD | $252.35 275.85 USD | $135.61B 148.24B USD | 26.88 | $9.38 10.25 USD | |
| Amgen Inc. AMGN.VI | $252.15 275.63 USD |
-0.67
|
$135.58B 148.21B USD | $0 0 USD | $251.85 275.31 USD | $252.15 275.63 USD | $135.58B 148.21B USD | 27.11 | $9.3 10.17 USD | |
| Amgen Inc. AMG.F | $251.1 274.49 USD |
-0.99
|
$135.02B 147.59B USD | $100 109.31 USD | $251.1 274.49 USD | $251.6 275.03 USD | $135.02B 147.59B USD | 27.17 | $9.24 10.1 USD | |
| Bristol-Myers Squibb Company BMY.BA | $19,825 23.43 USD |
+0.13
|
$121.67T 143.82B USD | $1.88K 2.22 USD | $19,575 23.14 USD | $20,250 23.94 USD | $121.67T 143.82B USD | 5.86 | $3.38K 4 USD | |
| Gilead Sciences, Inc. GILD.SN | $110.47 — |
+0.04
|
$140.91B — | $0 — | $0 — | $0 — | $140.91B — | 23.20 | $4.76 — | |
| Pfizer Inc. PFE.SN | $23.8 — |
-8.67
|
$135.31B — | $0 — | $23.8 — | $23.8 — | $135.31B — | 17.24 | $1.38 — | |
| Pfizer Inc. PFE.VI | $21.73 23.75 USD |
+0.21
|
$123.51B 135.02B USD | $583 637.3 USD | $21.71 23.73 USD | $21.75 23.78 USD | $123.51B 135.02B USD | 18.25 | $1.19 1.3 USD | |
| Pfizer Inc. PFEB.F | $7 7.65 USD |
-0.71
|
$122.7B 134.12B USD | $40 43.73 USD | $7 7.65 USD | $7 7.65 USD | $122.7B 134.12B USD | 17.94 | $0.39 0.43 USD | |
| Sanofi SANF.MI | $96.82 105.84 USD |
0
|
$121.24B 132.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $121.24B 132.54B USD | 0 | $0 0 USD | |
| Gilead Sciences, Inc. GIS.DE | $96.38 105.36 USD |
+0.27
|
$119.89B 131.06B USD | $40 43.73 USD | $96.38 105.36 USD | $96.38 105.36 USD | $119.89B 131.06B USD | 23.73 | $4.06 4.44 USD | |
| Gilead Sciences, Inc. GIS.F | $96.26 105.23 USD |
+0.33
|
$119.74B 130.89B USD | $252 275.47 USD | $96.26 105.23 USD | $96.26 105.23 USD | $119.74B 130.89B USD | 23.88 | $4.03 4.41 USD | |
| Gilead Sciences, Inc. GILD.VI | $96.1 105.05 USD |
-0.15
|
$119.54B 130.68B USD | $0 0 USD | $96.1 105.05 USD | $96.58 105.57 USD | $119.54B 130.68B USD | 23.78 | $4.04 4.42 USD | |
| GSK plc GSK.BA | $12,100 14.3 USD |
-0.41
|
$98.29T 116.18B USD | $145 0.17 USD | $12,075 14.27 USD | $12,325 14.57 USD | $98.29T 116.18B USD | 18.48 | $654.61 0.77 USD | |
| Sanofi SANO.VI | $84.04 91.87 USD |
+1.12
|
$103.79B 113.46B USD | $0 0 USD | $84.03 91.86 USD | $84.04 91.87 USD | $103.79B 113.46B USD | 17.04 | $4.93 5.39 USD | |
| Sanofi SNW2.F | $41.6 45.47 USD |
+0.97
|
$102.89B 112.48B USD | $100 109.31 USD | $41.6 45.47 USD | $41.6 45.47 USD | $102.89B 112.48B USD | 16.77 | $2.48 2.71 USD | |
| Sanofi SNW.F | $84.05 91.88 USD |
+0.74
|
$102.33B 111.86B USD | $200 218.63 USD | $83.31 91.07 USD | $84.05 91.88 USD | $102.33B 111.86B USD | 16.81 | $5 5.47 USD | |
| Bristol-Myers Squibb Company BMYB34.SA | $261.6 53.02 USD |
+0.77
|
$532.61B 107.95B USD | $0 0 USD | $0 0 USD | $0 0 USD | $532.61B 107.95B USD | 18.05 | $14.49 2.94 USD | |
| Bristol-Myers Squibb Company BMY.MX | $885 52.4 USD |
0
|
$1.81T 106.93B USD | $201 11.9 USD | $0 0 USD | $0 0 USD | $1.81T 106.93B USD | 17.73 | $49.91 2.96 USD | |
| Gilead Sciences, Inc. GILD.MI | $72.4 79.14 USD |
0
|
$90.19B 98.59B USD | $0 0 USD | $0 0 USD | $0 0 USD | $90.19B 98.59B USD | 0 | $0 0 USD | |
| GSK plc GSKN.MX | $791 46.84 USD |
0
|
$1.6T 94.67B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.6T 94.67B USD | 20.53 | $38.52 2.28 USD | |
| Bristol-Myers Squibb Company BRM.F | $40.9 44.71 USD |
+0.65
|
$83.23B 90.99B USD | $380 415.39 USD | $40.9 44.71 USD | $40.9 44.71 USD | $83.23B 90.99B USD | 17.93 | $2.28 2.49 USD | |
| Bristol-Myers Squibb Company BMYS.VI | $40.57 44.34 USD |
+0.3
|
$82.55B 90.24B USD | $0 0 USD | $40.5 44.27 USD | $40.57 44.34 USD | $82.55B 90.24B USD | 17.71 | $2.29 2.5 USD | |
| Bristol-Myers Squibb Company BRM.DE | $40.49 44.26 USD |
+0.22
|
$82.4B 90.07B USD | $125 136.64 USD | $40.49 44.26 USD | $40.49 44.26 USD | $82.4B 90.07B USD | 17.68 | $2.29 2.5 USD | |
| GSK plc G1SK34.SA | $42.38 8.59 USD |
+1.63
|
$434.57B 88.08B USD | $0 0 USD | $0 0 USD | $0 0 USD | $434.57B 88.08B USD | 19.09 | $2.22 0.45 USD | |
| Chugai Pharmaceutical CHGCF | $44.4 — |
-10.52
|
$76.26B — | $200 — | $52 — | $52 — | $76.26B — | 25.96 | $1.71 — | |
| Chugai Pharmaceutical Co., Ltd. CUP.F | $39.54 43.22 USD |
+0.23
|
$68.21B 74.57B USD | $1 1.09 USD | $39.54 43.22 USD | $39.56 43.24 USD | $68.21B 74.57B USD | 26.89 | $1.47 1.61 USD | |
| Bayer Aktiengesellschaft BAY.MI | $55.5 60.67 USD |
0
|
$55.21B 60.36B USD | $0 0 USD | $0 0 USD | $0 0 USD | $55.21B 60.36B USD | 0 | $0 0 USD | |
| Daiichi Sankyo Company, Limited D4S.F | $18.36 20.07 USD |
-0.84
|
$35.31B 38.6B USD | $50 54.66 USD | $18.36 20.07 USD | $18.36 20.07 USD | $35.31B 38.6B USD | 20.86 | $0.88 0.96 USD | |
| Bayer Aktiengesellschaft BAYZF | $32.03 — |
+0.91
|
$31.47B — | $2.5K — | $31.1 — | $31.1 — | $31.47B — | 0 | -$3.9 — | |
| Bayer Aktiengesellschaft BAYER.BD | $10,998 30.42 USD |
0
|
$10.8T 29.88B USD | $155 0.43 USD | $10,998 30.42 USD | $11,110 30.73 USD | $10.8T 29.88B USD | 0 | -$1,277 -3.5 USD | |
| Bayer Aktiengesellschaft BAYN.VI | $27.6 30.17 USD |
+0.97
|
$27.11B 29.63B USD | $1.16K 1.27K USD | $27.57 30.13 USD | $27.68 30.26 USD | $27.11B 29.63B USD | 0 | -$3.3 -3.6 USD | |
| Bayer Aktiengesellschaft BAYA.F | $6.7 7.32 USD |
-2.9
|
$27.11B 29.63B USD | $30 32.79 USD | $6.7 7.32 USD | $6.7 7.32 USD | $27.11B 29.63B USD | 0 | -$0.76 -0.8 USD | |
| Biogen Inc. BIIB.BA | $13,050 15.43 USD |
+1.75
|
$24.87T 29.39B USD | $10.29K 12.16 USD | $12,875 15.22 USD | $13,250 15.66 USD | $24.87T 29.39B USD | 1.02 | $12.77K 15.1 USD | |
| Otsuka Holdings Co., Ltd. OS1.F | $38 41.54 USD |
-2.56
|
$20.45B 22.36B USD | $150 163.97 USD | $38 41.54 USD | $38.8 42.41 USD | $20.45B 22.36B USD | 10.10 | $3.76 4.11 USD | |
| Biogen Inc. BIIB34.SA | $119.16 24.15 USD |
0
|
$108.18B 21.93B USD | $0 0 USD | $0 0 USD | $0 0 USD | $108.18B 21.93B USD | 13.02 | $9.15 1.85 USD | |
| Biogen Inc. BIIB.MX | $2,475.32 146.57 USD |
-2.34
|
$362.7B 21.48B USD | $5 0.3 USD | $2,475.32 146.57 USD | $2,475.32 146.57 USD | $362.7B 21.48B USD | 12.83 | $192.88 11.42 USD | |
| Biogen Inc. IDP.DE | $114 124.62 USD |
+0.04
|
$16.7B 18.26B USD | $50 54.66 USD | $114 124.62 USD | $114 124.62 USD | $16.7B 18.26B USD | 13.13 | $8.68 9.49 USD | |
| Biogen Inc. BIIB.VI | $113.45 124.02 USD |
-0.48
|
$16.62B 18.17B USD | $0 0 USD | $113.25 123.8 USD | $113.45 124.02 USD | $16.62B 18.17B USD | 13.11 | $8.65 9.46 USD | |
| Biogen Inc. IDP.F | $112.55 123.03 USD |
-1.32
|
$16.49B 18.03B USD | $25 27.33 USD | $112.55 123.03 USD | $112.55 123.03 USD | $16.49B 18.03B USD | 13.27 | $8.48 9.27 USD | |
| Astellas Pharma ALPMF | $9.46 — |
+0.96
|
$16.94B — | $100 — | $10.1 — | $10.1 — | $16.94B — | 49.78 | $0.19 — | |
| Astellas Pharma Inc. YPH.F | $7.92 8.66 USD |
+0.66
|
$14.57B 15.93B USD | $100 109.31 USD | $7.92 8.66 USD | $7.92 8.66 USD | $14.57B 15.93B USD | 49.51 | $0.16 0.17 USD | |
| Astellas Pharma Inc. YPHA.F | $7.75 8.47 USD |
0
|
$14.53B 15.89B USD | $26 28.42 USD | $7.75 8.47 USD | $7.75 8.47 USD | $14.53B 15.89B USD | 48.43 | $0.16 0.17 USD | |
| Cipla Limited CIPLA.BO | $1,477.55 17.88 USD |
-0.96
|
$1.21T 14.62B USD | $242.77K 2.94K USD | $1,463.1 17.7 USD | $1,491.45 18.04 USD | $1.21T 14.62B USD | 22.66 | $65.19 0.79 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. RER1.F | $54.05 59.08 USD |
+1.12
|
$11.31B 12.36B USD | $30 32.79 USD | $54.05 59.08 USD | $54.05 59.08 USD | $11.31B 12.36B USD | 27.16 | $1.99 2.18 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. REC.VI | $54.2 59.25 USD |
+1.12
|
$11.3B 12.35B USD | $0 0 USD | $54.2 59.25 USD | $54.3 59.36 USD | $11.3B 12.35B USD | 27.23 | $1.99 2.18 USD | |
| CSPC Pharmaceutical CHJTF | $1.05 — |
0
|
$11.99B — | $19.71K — | $1.05 — | $1.05 — | $11.99B — | 20.99 | $0.05 — | |
| CSPC Pharmaceutical CSPCY | $4.12 — |
+2.11
|
$11.77B — | $10K — | $4.12 — | $4.12 — | $11.77B — | 19.61 | $0.21 — | |
| CSPC Pharmaceutical Group Limited CVGU.F | $3.28 3.59 USD |
0
|
$10.11B 11.05B USD | $4.69K 5.12K USD | $3.28 3.59 USD | $3.28 3.59 USD | $10.11B 11.05B USD | 19.29 | $0.17 0.19 USD | |
| CSPC Pharmaceutical Group Limited CVG.F | $0.8599 0.94 USD |
-2.95
|
$10.1B 11.04B USD | $1.5K 1.64K USD | $0.8599 0.94 USD | $0.8599 0.94 USD | $10.1B 11.04B USD | 21.57 | $0.04 0.04 USD | |
| Orion Oyj ORINY | $37.81 — |
0
|
$10.81B — | $6 — | $38.37 — | $38.37 — | $10.81B — | 25.89 | $1.46 — | |
| Orion Oyj OFK0.F | $32.8 35.85 USD |
0
|
$9.24B 10.1B USD | $0 0 USD | $32.8 35.85 USD | $32.8 35.85 USD | $9.24B 10.1B USD | 27.56 | $1.19 1.3 USD | |
| Orion Oyj OFK.F | $65.7 71.82 USD |
-0.3
|
$8.91B 9.74B USD | $15 16.4 USD | $65.7 71.82 USD | $65.7 71.82 USD | $8.91B 9.74B USD | 26.59 | $2.47 2.7 USD | |
| Kyowa Kirin KYKOF | $14.95 — |
0
|
$8.94B — | $63 — | $16.75 — | $16.75 — | $8.94B — | 22.31 | $0.67 — | |
| Abbott India Limited ABBOTINDIA.BO | $34,635 419.03 USD |
+0.83
|
$738.31B 8.93B USD | $117 1.42 USD | $34,130 412.92 USD | $34,699.9 419.81 USD | $738.31B 8.93B USD | 51.97 | $666.4 8.06 USD | |
| Abbott India Limited ABBOTINDIA.NS | $34,555 418.06 USD |
+0.48
|
$735.75B 8.9B USD | $4.4K 53.21 USD | $34,125 412.86 USD | $34,845 421.57 USD | $735.75B 8.9B USD | 51.79 | $667.17 8.07 USD | |
| Kyowa Kirin Co., Ltd. KY4.F | $14.4 15.74 USD |
-0.69
|
$7.7B 8.42B USD | $30 32.79 USD | $14.3 15.63 USD | $14.4 15.74 USD | $7.7B 8.42B USD | 25.71 | $0.56 0.61 USD | |
| Grifols, S.A. GIFOF | $8.82 — |
0
|
$8.13B — | $4.41K — | $8.18 — | $8.25 — | $8.13B — | 32.64 | $0.27 — | |
| Grifols GIFLF | $11.45 — |
0
|
$8.13B — | $1.33K — | $10.95 — | $10.95 — | $8.13B — | 42.40 | $0.27 — | |
| Grifols, S.A. GIKLY | $6.7 — |
+9.12
|
$8.13B — | $8K — | $6.64 — | $6.7 — | $8.13B — | 51.53 | $0.13 — | |
|
Favori hisse senedi yok.
Henüz favori bir hisse senediniz yok, lütfen burada görmek için favorilere ekleyin |
||||||||||
- {{ link.label }} {{link}}